Sermonix Pharmaceuticals, Inc. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-10-28
3:37 pm
Sale
2026-10-2613DLEONABIO INC
LONA
Sermonix Pharmaceuticals, Inc.3,149,470
25.100%
-2,352,932decrease
(-42.76%)
Filing
History
2026-08-31
4:31 pm
Purchase
2026-08-2413DLEONABIO INC
LONA
Sermonix Pharmaceuticals, Inc.5,502,402
36.900%
5,502,402increase
(New Position)
Filing
History